Curis | CRIS - Ebitda





Ebitda Cambiamento Data
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Bayer EUR 1.97B 457M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
CSL USD 3.13B 1.17B 2025-12
Curis USD -12.3M 231K 2023-09
Eli Lilly USD 7.88B 378.1M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Incyte USD 414.5M 92.42M 2025-12
Merck USD 8.39B 1.97B 2025-09
Novartis USD 4.77B 1.11B 2025-12
Pfizer USD 6.08B 351M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Takeda JPY 448.13B 173.98B 2025-12
TG Therapeutics USD 32.69M 5M 2025-09
Xoma USD 2.52M 7.98M 2024-06